State Street Corp Synlogic, Inc. Transaction History

State Street Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.89 - $2.47 $23,601 - $65,501	26,519 Added 20.76%	154,284 $177,000
Q1 2022 May 16, 2022	BUY	$1.63 - $2.55 $67,659 - $105,847	41,509 Added 48.12%	127,765 $307,000
Q3 2021 Nov 15, 2021	BUY	$2.45 - $4.1 $27,440 - $45,919	11,200 Added 14.92%	86,256 $263,000
Q2 2021 Aug 16, 2021	BUY	$3.0 - $4.39 $225,168 - $329,495	75,056 New	75,056 $292,000
Q3 2020 Nov 10, 2020	SELL	$1.85 - $2.57 $24,623 - $34,206	-13,310 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.59 - $2.51 $460,471 - $726,908	-289,605 Reduced 95.61%	13,310 $27,000
Q1 2020 May 11, 2020	BUY	$1.39 - $3.19 $421,051 - $966,298	302,915 New	302,915 $521,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.